|
CTNM Contineum Therapeutics Inc 1855175 |
| Balance Sheet |
|
Current Assets
|
206,388,000 |
|
Assets
|
212,847,000 |
|
Current Liabilities
|
9,974,000 |
|
Liabilities
|
14,781,000 |
|
Equity
|
198,066,000 |
|
Shares Out
|
18,994,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-32,845,000 |
|
Investing Cash Flow
|
-69,739,000 |
| Market Analysis |
Market Cap
|
421,861,618 |
|
Price
|
7.42 |
|
BVPS
|
10.43 |
|
PB
|
0.71 |
|
EPS
|
-1.24 |
|
PS
|
0.79 |
|
FCF
|
-102,584,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view CTNM documents filed with the SEC.
CTNM Filings
Clear
